2022 Revenues ($USD) : $665,904,953
2022 Revenues (foreign currencies) : JP¥73,143,000,000
2022 R&D spend : n/a
2022 Number of Employees : n/a
Fiscal Year End : 12/31/2021
Company CEO : Toshihiko Kai, president and CEO

Nikkiso has been a significant provider of dialysis machines in Japan and around the world; it holds more than half of the market in Japan. The company has also expanded into devices related to blood purification, perioperative and emergency settings, and surgery. It also has an artificial pancreas technology for use in clinical settings.  –CN